Health and Wellness Informatics News
Aster DM Healthcare is going to expand its application of technologies based on AI. One such example of this is the Aster CMI Hospital. It will work first to enhance technology in the field of neurology.
The Aster Healthcare Group collaborated with Intel and CARPL.ai to bring forward AI health. This program aims to mingle AI and health to form a health data platform in India. India is currently trying to pace up its healthcare with effective technology.
Intel is using OpenFL. This is one of its open systems for algorithms of machine learning. Unfortunately, this got mixed with CARPL.ai’s collected data to enhance AI training.
The Intel Software Extensions are also under use to enhance the security of health data. The AI health platform is going to get under trial. They will also get under trials in the Aster hospitals in Kerala, Vijayawada, and Bengaluru.
The CheXNet model got trained by the extraction of 125,000 x-rays of the chest. Therefore, every patient generates around 80 MB of data based on imaging. However, RBC Capital Market states that the CAGR of healthcare data will reach 36% by 2025.
AI health data platforms prove that they can bring benefits in solving many healthcare conflicts. For example, it can solve problems like lacking staff members and poor accessibility of data at different locations. It also helps with many other issues of regulatory policies.
Nivruti Rai, Intel India Head, stated that geographic boundaries and limitations in frameworks are some issues in the development of AI Solutions. The platform will also predict the training model of AI health.
Aster DM Healthcare is going to expand its application of technologies based on AI. One such example of this is the Aster CMI Hospital. It will also work first to enhance technology in the field of neurology.
Dr. Azad Moopen, chairman and founder of Aster DM Healthcare, stated, “So far, only a few such initiatives have been conducted, especially in the healthcare space; their health data platform will support the development of a predictive mechanism for patients, the opportunity for a second opinion on treatments, and most importantly, affirming data security and confidentiality of patients.”
CARPL.ai CEO Dr. Vidur Mahajan also mentioned that the future is about the training and monitoring of AI health in an associated manner.